Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3
Open Access
- 7 March 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (10), 1819-1823
- https://doi.org/10.1182/blood-2012-08-451690
Abstract
Key Points Presence of more than 3 PET focal lesions after day 7 first cycle of induction chemotherapy can predict for inferior overall survival and progression free survival.Keywords
This publication has 13 references indexed in Scilit:
- Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling dataHaematologica, 2012
- Imaging of Multiple Myeloma and Related Plasma Cell DyscrasiasJournal of Nuclear Medicine, 2012
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantationBlood, 2011
- Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenanceBlood, 2010
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myelomaPublished by American Society of Hematology ,2009
- Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3British Journal of Haematology, 2007
- Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical ImplicationsJournal of Clinical Oncology, 2007
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Evaluation of survival data and two new rank order statistics arising in its consideration.1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958